N Acetylcysteine (Nac) Therapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...
N-Acetylcysteine (NAC) Therapy for Neurodegeneration
N Acetylcysteine (Nac) Therapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
N-Acetylcysteine (NAC) Therapy is a glutathione-boosting therapeutic approach for neurodegenerative diseases. NAC is a precursor to glutathione, the body's most important endogenous antioxidant. It helps restore intracellular glutathione levels, reduce oxidative stress, and protect [neurons](/entities/neurons) from damage in Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative disorders. [@tardiolo2018]
Mechanism of Action
N-Acetylcysteine is a sulfhydryl compound that serves as a precursor to L-cysteine, which is rate-limiting for glutathione synthesis. The therapeutic effects involve multiple interconnected pathways. [@montes2021]
Key Molecular Mechanisms: [@koh2020]
Glutathione Restoration — NAC provides cysteine for de novo glutathione synthesis, replenishing depleted antioxidant stores
Direct Antioxidant Effects — NAC directly scavenges [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) and reactive nitrogen species (RNS)
Mitochondrial Protection — NAC preserves mitochondrial function by reducing oxidative damage to ETC components
The study of N Acetylcysteine (Nac) Therapy For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[NAC and glutathione (PubMed)](https://pubmed.ncbi.nlm.nih.gov/?term=N-acetylcysteine+neurodegeneration)
[Clinical trials of NAC (ClinicalTrials.gov)](https://clinicaltrials.gov/search?cond=neurodegenerative+disease&intr=N-acetylcysteine)
References
[Liu J, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29427796/)
[Tardiolo G, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/30562935/)
[Montes S, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33430456/)
[Koh J, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32193828/)
[Berk M, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18626999/)
[Odetti P, et al, (1998) (1998)](https://pubmed.ncbi.nlm.nih.gov/9706375/)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate